For Authors

HOME >  For Authors

Call for Participation

CHI 2021 offers authors a number of ways to publish and present work, to interact, discuss and learn, along with dedicated opportunities for students. Each type of submission and its deadlines are described on the pages linked which follow. However, if you are new to CHI, we would encourage you to first read the "New to CHI" section at the end of this page.

 

Submission Process

We use the new ACM master article template for all the submissions. This is new for CHI 2021 so please read the explanation carefully. All submissions are made through the Precision Conference System (PCS 2.0).

 

Are you new to CHI?

In the CHI conference, and hence the CHI conference proceedings, there are different types of submission with different deadlines. This can seem a little daunting so it's worth knowing these three key things:

  1. Which type of submission, are you aiming for? Links to prior CHI conference proceedings can help you better understand the nature of each submission type.
  2. CHI uses a selection process for each type of submission, with different levels of review, feedback, and opportunities for republication.
  3. Do you know the deadline for your submission type? Dates are listed on the page for each type of submission.

 

COVID-19

The COVID-19 pandemic has claimed many lives and impacted many people around the world, including members of the CHI community. The organisers of CHI 2021 recognise this has also disrupted research activities worldwide. For example, in-person user studies for validating research artefacts will be impossible to conduct in many countries and regions. However, user studies are not the only possible means of assessing a research contribution. We ask authors to consider the many ways in which the validity of your submission’s contribution can be evidenced. For papers submission, our “Guide to a Successful Submission” describes how to ensure results are valid, and importantly user studies are only one of the approaches to demonstrating validity. We encourage you to read our COVID-19 blog post for further details.

HOME >  For Authors
pagetop